<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Inthanon K</submitter><funding>Chiang Mai University</funding><funding>Bualuang ASEAN Chair Professorship</funding><funding>Mitacs</funding><funding>Thammasat University</funding><pagination>4051</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11790873</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Obesity poses a significant global health challenge, necessitating the search for novel therapeutic agents to address this epidemic. Chromenes, known for their diverse bioactivities, hold promise as potential anti-obesity compounds, yet research in this area remains limited. This pioneering study represents the first exploration of synthetic chromenes as potential anti-obesity agents, unveiling the underlying molecular pathways governing adipogenesis and lipolysis. Twenty-nine chromenes were synthesized using green chemistry approaches, resulting in five novel compounds: 1, 2, 3, 4, and 5. Among them, 14 chromenes demonstrated a lack of toxicity to pre-adipocytes (PAs) and mature adipocytes (MAs) of 3T3-L1 cells. The anti-adipogenesis and lipolysis enhancement potential of these non-toxic </pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.</pubmed_title><pmcid>PMC11790873</pmcid><funding_grant_id>TUFT65/2567</funding_grant_id><funding_grant_id>256108A1040047</funding_grant_id><pubmed_authors>Inthanon K</pubmed_authors><pubmed_authors>Kittakoop P</pubmed_authors><pubmed_authors>Guerra AG</pubmed_authors><pubmed_authors>Sangher S</pubmed_authors><pubmed_authors>Kesornpun C</pubmed_authors><pubmed_authors>Wong-A-Nan N</pubmed_authors><pubmed_authors>Dheeranupattana S</pubmed_authors><pubmed_authors>Davies NM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.</name><description>Obesity poses a significant global health challenge, necessitating the search for novel therapeutic agents to address this epidemic. Chromenes, known for their diverse bioactivities, hold promise as potential anti-obesity compounds, yet research in this area remains limited. This pioneering study represents the first exploration of synthetic chromenes as potential anti-obesity agents, unveiling the underlying molecular pathways governing adipogenesis and lipolysis. Twenty-nine chromenes were synthesized using green chemistry approaches, resulting in five novel compounds: 1, 2, 3, 4, and 5. Among them, 14 chromenes demonstrated a lack of toxicity to pre-adipocytes (PAs) and mature adipocytes (MAs) of 3T3-L1 cells. The anti-adipogenesis and lipolysis enhancement potential of these non-toxic </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-02T20:05:50.043Z</modification><creation>2025-04-04T00:54:51.951Z</creation></dates><accession>S-EPMC11790873</accession><cross_references><pubmed>39900791</pubmed><doi>10.1038/s41598-025-87945-1</doi></cross_references></HashMap>